JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 59 filers reported holding JANUX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,000 | +61.9% | 3,397 | +90.5% | 0.00% | – |
| Q2 2023 | $21,000 | +75.0% | 1,783 | +85.7% | 0.00% | – |
| Q1 2023 | $12,000 | -57.1% | 960 | -56.0% | 0.00% | – |
| Q4 2022 | $28,000 | +833.3% | 2,181 | +832.1% | 0.00% | – |
| Q3 2022 | $3,000 | +200.0% | 234 | +141.2% | 0.00% | – |
| Q2 2022 | $1,000 | -93.8% | 97 | -91.1% | 0.00% | – |
| Q1 2022 | $16,000 | -72.4% | 1,092 | -63.0% | 0.00% | – |
| Q4 2021 | $58,000 | -4.9% | 2,952 | +4.1% | 0.00% | – |
| Q3 2021 | $61,000 | +90.6% | 2,837 | +118.2% | 0.00% | – |
| Q2 2021 | $32,000 | – | 1,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $105,869,000 | 2.82% |
| 5AM Venture Management, LLC | 446,266 | $5,449,000 | 1.35% |
| Samsara BioCapital, LLC | 360,414 | $4,401,000 | 1.17% |
| BVF INC/IL | 1,470,334 | $17,953,000 | 0.87% |
| Orbimed Advisors | 2,836,386 | $34,632,000 | 0.63% |
| EcoR1 Capital, LLC | 1,421,319 | $17,354,000 | 0.60% |
| Parkwood LLC | 33,750 | $412,000 | 0.07% |
| Woodline Partners LP | 286,383 | $3,497,000 | 0.05% |
| Cerity Partners LLC | 150,933 | $1,843,000 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,127,797 | $25,966,000 | 0.02% |